Translational Development Acquisition Corp. (TDACW)
NASDAQ: TDACW · Real-Time Price · USD · Warrants
0.2121
-0.0679 (-24.25%)
Jun 6, 2025, 4:00 PM - Market closed
Company Description
Translational Development Acquisition Corp. does not have significant operations.
It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Translational Development Acquisition Corp.
| Country | United States |
| Founded | 2022 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Michael M. Hoffman |
Contact Details
Address: 52 E. 83rd Street New York, New York 10028 United States | |
| Phone | 917 979 3072 |
| Website | translational-development.com |
Stock Details
| Ticker Symbol | TDACW |
| Exchange | NASDAQ |
| Stock Type | Warrants |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001673481 |
| CUSIP Number | 89615T114 |
Key Executives
| Name | Position |
|---|---|
| Michael M. Hoffman | Chief Executive Officer |
| Avi Das | Chief Financial Officer |